Category: DTC Advertising

DTC Advertising

DTC Advertising

Oregon Considers Drug Price Disclosures in All Consumer Ads

Oregon Considers Drug Price Disclosures in All Consumer Ads

Feb. 25, 2019 – Even as the Centers for Medicare & Medicaid Services considers comments received on a federal proposal to mandate the inclusion of the wholesale acquisition cost (WAC) of prescription drugs in consumer television ads, the state of Oregon is weighing whether or not to require a disclosure regarding the wholesale cost that […]

Read more

DTC Advertising

J&J, Lilly Make Voluntary Moves to Share Broader Price Info in DTC TV Ads

J&J, Lilly Make Voluntary Moves to Share Broader Price Info in DTC TV Ads

Feb. 11, 2019 – Last week Johnson & Johnson announced that it would include both the list price of a drug and information about what patients realistically might expect to pay out of pocket for its drugs in direct-to-consumer (DTC) ads by the end of the first quarter, starting with Xarelto, its most-prescribed medication. This […]

Read more

DTC Advertising

Patients: DTC Ad Drug Price Transparency Proposed Rule Needs More Context, Expanded Scope

Patients: DTC Ad Drug Price Transparency Proposed Rule Needs More Context, Expanded Scope

Feb. 5, 2019 – Patient and disease advocacy groups have weighed in on the Centers for Medicare & Medicaid Services (CMS) proposal to require that drug companies list the wholesale acquisition cost (WAC) for their drugs in televised direct-to-consumer (DTC) ads. Their comments to CMS raise issues about whether the proposed rule asks for disclosure […]

Read more

DTC Advertising

Many Physician Groups Call for Broader DTC Ad Price Disclosure, Greater Penalties for Violators

Many Physician Groups Call for Broader DTC Ad Price Disclosure, Greater Penalties for Violators

Jan. 29, 2019 — Although industry trade groups filing comments on the Centers for Medicare & Medicaid Services (CMS) proposal to require including the wholesale acquisition cost (WAC) in television ads for prescription drugs were largely agreed in their positions against the idea (as reported here), comments from physician organizations and specialty groups were more […]

Read more

DTC Advertising

Trade Groups Say CMS Lacks Authority to Mandate Drug Prices in DTC TV Ads

Trade Groups Say CMS Lacks Authority to Mandate Drug Prices in DTC TV Ads

Jan. 15, 2019 – In comments to the Centers for Medicare and Medicaid Services (CMS) regarding its proposal to require that drug companies include the wholesale acquisition cost (WAC) of a drug in direct-to-consumer (DTC) television ads, industry trade groups and pharmaceutical companies largely are in agreement that doing so would confuse consumers, that CMS […]

Read more

DTC Advertising

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

CHC Cites Practical, Legal Concerns in Comment to CMS on Drug Prices in DTC Ads

Dec. 17, 2018 – The Coalition for Healthcare Communication (CHC) finds the recent proposal to require drug list prices in direct-to-consumer (DTC) television ads “detrimental to the interests of both health providers and patients,” and raises numerous practical and legal concerns to support that position in its official comment filed Dec. 14 with the Centers […]

Read more

DTC Advertising

NEJM: Drug Price Information in DTC Ads Raises Public Health, Legal Concerns

NEJM: Drug Price Information in DTC Ads Raises Public Health, Legal Concerns

Nov. 19, 2018 – In a featured “Perspective” article in The New England Journal of Medicine (NEJM) this week, Stacie B. Dusetzina, Ph.D., and Michelle M. Mello, J.D., Ph.D., state that although providing cost information about prescription drugs is valuable, mandating that companies use the wholesale acquisition cost (WAC) in direct-to-consumer (DTC) ads “raises substantial […]

Read more

DTC Advertising

OPDP Guidance on Presenting Risk, Efficacy Info in DTC Ads Calls for Consumer-friendly Approaches

OPDP Guidance on Presenting Risk, Efficacy Info in DTC Ads Calls for Consumer-friendly Approaches

Oct. 19, 2018 – It is important for drug companies to make quantitative presentations of risk or efficacy information in direct-to-consumer (DTC) ads more consumer friendly, according to draft guidance issued by the FDA’s Office of Prescription Drug Promotion (OPDP). The draft guidance, “Presenting Quantitative Efficacy and Risk Information in [DTC] Promotional Labeling and Advertisements,” […]

Read more

DTC Advertising

HHS’ Azar Announces Proposed Rule Requiring DTC Ad Price Disclosures

HHS’ Azar Announces Proposed Rule Requiring DTC Ad Price Disclosures

Oct. 16, 2018 – Yesterday morning, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced a program under which member companies would refer patients to online information about medicine costs in direct-to-consumer (DTC) ads. But then yesterday afternoon, Department of Health and Human Services (HHS) Secretary Alex Azar made clear that this effort would not […]

Read more

DTC Advertising

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Amendment to Fund Drug Prices in Ads Dropped to Avert Derailment of HHS Spending Bill

Sept. 24, 2018 — With the amendment to fund the implementation of mandatory drug prices in consumer advertising stripped out of the spending bill to which it had been attached, the question of whether or how quickly this drug pricing mandate will move forward remains unclear. The amendment, from Sens. Dick Durbin (D-Ill.) and Charles […]

Read more